Shamim Rashid
Overview
Explore the profile of Shamim Rashid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ronzoni S, Rashid S, Santoro A, Mei-Dan E, Barrett J, Okun N, et al.
BMC Pregnancy Childbirth
. 2025 Jan;
25(1):32.
PMID: 39815166
Background: Preeclampsia significantly impacts maternal and perinatal health. Early screening using advanced models and primary prevention with low-dose acetylsalicylic acid for high-risk populations is crucial to reduce the disease's incidence....
2.
Huang T, Rashid S, Priston M, Rasasakaram E, Mak-Tam E, Gibbons C, et al.
AJOG Glob Rep
. 2023 May;
3(2):100193.
PMID: 37168546
Background: Professional societies have recommended universal first trimester screening for preeclampsia and a second or third trimester soluble fms-like tyrosine kinase-1-placental growth factor ratio test to assess for preeclampsia and...
3.
Huang T, Bedford H, Rashid S, Rasasakaram E, Priston M, Mak-Tam E, et al.
BMC Pregnancy Childbirth
. 2022 Mar;
22(1):190.
PMID: 35260099
Background: Abnormal levels of maternal biochemical markers used in multiple marker aneuploidy screening have been associated with adverse pregnancy outcomes. This study aims to assess if a combination of maternal...
4.
Huang T, Gibbons C, Rashid S, Priston M, Bedford H, Mak-Tam E, et al.
BMC Pregnancy Childbirth
. 2020 Nov;
20(1):713.
PMID: 33228595
Background: Prenatal screening for chromosome aneuploidies have constantly been evolving, especially with the introduction of cell-free fetal DNA (cfDNA) screening in the most recent years. This study compares the performance,...
5.
Huang T, Meschino W, Rashid S, Dennis A, Mak-Tam E, Cuckle H
J Obstet Gynaecol Can
. 2018 Jul;
40(10):1295-1301.
PMID: 30025867
Objectives: To assess the performance of first trimester combined screening (FTS) when enhanced with placental growth factor and alpha feto-protein in the detection of trisomies 18 and 13. Methods: A...
6.
Huang T, Dennis A, Meschino W, Rashid S, Mak-Tam E, Cuckle H
Prenat Diagn
. 2015 Apr;
35(7):709-16.
PMID: 25846403
Objective: The aim of this study was to assess the screening performance for Down syndrome using first trimester combined screening (FTS) and two additional markers, serum placental growth factor (PlGF)...
7.
Huang T, Boucher K, Aul R, Rashid S, Meschino W
Prenat Diagn
. 2014 Sep;
35(1):90-6.
PMID: 25200921
Objective: The aim of this study was to assess the concentration of the first and second trimester maternal serum markers in pregnancies with a vanishing twin. Methods: This is a...
8.
Huang T, Meschino W, Okun N, Dennis A, Hoffman B, Lepage N, et al.
Prenat Diagn
. 2013 Mar;
33(5):471-6.
PMID: 23512612
Objective: This study aimed to assess the quantitative impact of maternal weight discrepancy on the screen result for Down syndrome when using Integrated Prenatal Screening and First Trimester Combined Screening....
9.
Lepage N, Chaudhry A, Konforte D, Shaw J, Veljkovic K, Dennis A, et al.
Clin Biochem
. 2012 Jun;
45(15):1152-7.
PMID: 22732525
Background/objectives: The Ontario Prenatal Screening Program (OPSP) follows internationally recognized standardized procedures for laboratories and genetics clinics. However, it has been found that some procedures are subject to interpretation, so...